Cytox has launched a noninvasive genetic test, called genoSCORE-LAB, that can help to predict a person’s risk of developing Alzheimer’s disease and the cognitive decline it brings. Early detection of possible risk for this progressive, degenerative disease could encourage lifestyle changes that might slow Alzheimer’s onset and the rate of cognitive loss, the company reports in a press release. The test, which uses a blood or saliva sample, has received the CE mark in Europe, and will also…
You must be logged in to read/download the full post.
The post Noninvasive Genetic Risk Test for Alzheimer’s Coming to EU, US appeared first on BioNewsFeeds.